Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Recent filings

View:

Post by Mole101 on Feb 17, 2022 3:51pm

Recent filings

Recent filings
2022-02-1612:09 2022-02-10	$PMN	Williams, Eugene Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$420,000 +3,000,000vol $0.14 each	10,948,583
2022-02-1612:05 2022-02-10	$PMN	Cashman, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$420,000 +3,000,000vol $0.14 each	9,948,583

294

Comment

Comment by Speyeder999 on Feb 18, 2022 3:35pm

Thanks for sharing Mole. I have limited understandings of options and warrants, so can you or someone please explain the exercise of these options were to buy existing shares directly between brokerage firms ("transfer in kind" I think is the proper term) or were they newly emitted shares?

131

Comment

Comment by Gbathat on Feb 19, 2022 8:28pm

So the people with the most knowledge about the company and technology, respectively, just bought $840,000 CAD of stock by exercising options. That is great news! Maybe now they can let the price run a bit, eh?

173

Comment